152 related articles for article (PubMed ID: 35641599)
21.
Lin F; Yang Z; Qiu Y; Zeng W; Liu G; Zhang J
Infect Drug Resist; 2021; 14():5005-5013. PubMed ID: 34866920
[TBL] [Abstract][Full Text] [Related]
22. Characterization of anti-interferon-γ antibodies in HIV-negative immunodeficient patients infected with unusual intracellular microorganisms.
Wipasa J; Chaiwarith R; Chawansuntati K; Praparattanapan J; Rattanathammethee K; Supparatpinyo K
Exp Biol Med (Maywood); 2018 Apr; 243(7):621-626. PubMed ID: 29512397
[TBL] [Abstract][Full Text] [Related]
23. Coinfection of disseminated Talaromyces marneffei and Mycobacteria kansasii in a patient with papillary thyroid cancer: A case report.
Zhang J; Huang X; Zhang X; Zhu Y; Liao K; Ma J; Wang G; Guo Y; Xie C
Medicine (Baltimore); 2017 Dec; 96(52):e9072. PubMed ID: 29384899
[TBL] [Abstract][Full Text] [Related]
24. Peripheral immune profile of children with Talaromyces marneffei infections: a retrospective analysis of 21 cases.
Zeng Q; Jin Y; Yin G; Yang D; Li W; Shi T; Lu G; Huang L; Fan H
BMC Infect Dis; 2021 Mar; 21(1):287. PubMed ID: 33743629
[TBL] [Abstract][Full Text] [Related]
25. Pathogenicity of Mycolicibacterium phlei, a non-pathogenic nontuberculous mycobacterium in an immunocompetent host carrying anti-interferon gamma autoantibodies: a case report.
Tanaka S; Hoshino Y; Sakagami T; Fukano H; Matsui Y; Hiranuma O
BMC Infect Dis; 2019 May; 19(1):454. PubMed ID: 31117976
[TBL] [Abstract][Full Text] [Related]
26. Non-tuberculous mycobacterial infection and reactive dermatosis associated with adult-onset immunodeficiency due to anti-interferon-gamma autoantibodies: A case report.
Liang XN; Bin YF; Lai GT; Li YH; Zhang JQ; Zhong XN; Bai J; Li MH; Deng JM; He ZY
Medicine (Baltimore); 2020 Sep; 99(36):e21738. PubMed ID: 32899003
[TBL] [Abstract][Full Text] [Related]
27. Anti-Interferon-γ Autoantibodies Impair T-Lymphocyte Responses in Patients with
Chen ZM; Yang XY; Li ZT; Guan WJ; Qiu Y; Li SQ; Zhan YQ; Lei ZY; Liu J; Zhang JQ; Wang ZF; Ye F
Infect Drug Resist; 2022; 15():3381-3393. PubMed ID: 35789796
[TBL] [Abstract][Full Text] [Related]
28. A case report of Talaromyces marneffei Oro-pharyngo-laryngitis: a rare manifestation of Talaromycosis.
Wongkamhla T; Chongtrakool P; Jitmuang A
BMC Infect Dis; 2019 Dec; 19(1):1034. PubMed ID: 31805893
[TBL] [Abstract][Full Text] [Related]
29. Clinical implications of autoantibodies in HIV infection.
Massabki PS; Accetturi C; Nishie IA; da Silva NP; Sato EI; Andrade LE
AIDS; 1997 Dec; 11(15):1845-50. PubMed ID: 9412703
[TBL] [Abstract][Full Text] [Related]
30. Talaromyces Marneffei Infection in an HIV-Negative Child with a CARD9 Mutation in China: A Case Report and Review of the Literature.
You CY; Hu F; Lu SW; Pi DD; Xu F; Liu CJ; Fu YQ
Mycopathologia; 2021 Aug; 186(4):553-561. PubMed ID: 34224076
[TBL] [Abstract][Full Text] [Related]
31. Comparison of Talaromyces marneffei Infection in Human Immunodeficiency Virus-positive and Human Immunodeficiency Virus-negative Patients from Fujian, China.
Li HR; Cai SX; Chen YS; Yu ME; Xu NL; Xie BS; Lin M; Hu XL
Chin Med J (Engl); 2016 May; 129(9):1059-65. PubMed ID: 27098791
[TBL] [Abstract][Full Text] [Related]
32. Isotypes and IgG subclasses of anti-Fab antibodies in human immunodeficiency virus-infected hemophilia patients.
Süsal C; Oberg HH; Daniel V; Dörr C; Terness P; Huth-Kühne A; Zimmermann R; Opelz G
Vox Sang; 1994; 66(1):37-45. PubMed ID: 7908473
[TBL] [Abstract][Full Text] [Related]
33. Immunological and epidemiological evaluation of EBV infections among HIV-1 infected individuals in Abakaliki, Nigeria supports the potential use of neutrophils as a marker of EBV in HIV disease progression and as useful markers of immune activation.
Okonko IO; Makinde TS; Okonko BJ; Ogbu O
J Immunoassay Immunochem; 2020; 41(2):158-170. PubMed ID: 31885335
[TBL] [Abstract][Full Text] [Related]
34. Application of Flow Cytometry in the Diagnostics Pipeline of Primary Immunodeficiencies Underlying Disseminated
Lee PP; Lao-Araya M; Yang J; Chan KW; Ma H; Pei LC; Kui L; Mao H; Yang W; Zhao X; Trakultivakorn M; Lau YL
Front Immunol; 2019; 10():2189. PubMed ID: 31572394
[No Abstract] [Full Text] [Related]
35. Disseminated
Ding X; Huang H; Zhong L; Chen M; Peng F; Zhang B; Cui X; Yang XA
Front Cell Infect Microbiol; 2021; 11():605589. PubMed ID: 33791233
[TBL] [Abstract][Full Text] [Related]
36. Retrospective Analysis of 10 Cases of Disseminated Nontuberculous Mycobacterial Disease with Osteolytic Lesions.
Tang M; Huang J; Zeng W; Huang Y; Lei Y; Qiu Y; Zhang J
Infect Drug Resist; 2021; 14():4667-4679. PubMed ID: 34785914
[TBL] [Abstract][Full Text] [Related]
37. Daratumumab (Anti-CD38) for Treatment of Disseminated Nontuberculous Mycobacteria in a Patient With Anti-Interferon-γ Autoantibodies.
Ochoa S; Ding L; Kreuzburg S; Treat J; Holland SM; Zerbe CS
Clin Infect Dis; 2021 Jun; 72(12):2206-2208. PubMed ID: 32745179
[TBL] [Abstract][Full Text] [Related]
38. Effects of Talaromyces marneffei infection on mortality of HIV/AIDS patients in southern China: a retrospective cohort study.
Jiang J; Meng S; Huang S; Ruan Y; Lu X; Li JZ; Wu N; Huang J; Xie Z; Liang B; Deng J; Zhou B; Chen X; Ning C; Liao Y; Wei W; Lai J; Ye L; Wu F; Liang H
Clin Microbiol Infect; 2019 Feb; 25(2):233-241. PubMed ID: 29698815
[TBL] [Abstract][Full Text] [Related]
39. B lymphocyte stimulator protein-associated increase in circulating autoantibody levels may require CD4+ T cells: lessons from HIV-infected patients.
Stohl W; Cheema GS; Briggs WS; Xu D; Sosnovtseva S; Roschke V; Ferrara DE; Labat K; Sattler FR; Pierangeli SS; Hilbert DM
Clin Immunol; 2002 Aug; 104(2):115-22. PubMed ID: 12165272
[TBL] [Abstract][Full Text] [Related]
40. Susceptibility to opportunistic infections in HIV-infected patients with increased CD4 T-cell counts on antiretroviral therapy may be predicted by markers of dysfunctional effector memory CD4 T cells and B cells.
French M; Keane N; McKinnon E; Phung S; Price P
HIV Med; 2007 Apr; 8(3):148-55. PubMed ID: 17461858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
